Ftse Mib
34.816,78
-1,64%
DAX
18.767,21
0,32%
S&P 500
5.320,94
0,33%
NASDAQ
16.793,74
0,65%
Bitcoin
67.373,66
1,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Essa Pharma Inc (EPI) Essa Pharma Inc (EPI) Notizie

EPI

Essa Pharma (EPI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:EPI
DataOraFonteTitoloSimboloCompagnia
26/02/202100:33PR Newswire (Canada)ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of ShareholdersTSXV:EPIEssa Pharma Inc
13/01/202113:00PR Newswire (Canada)ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...TSXV:EPIEssa Pharma Inc
15/12/202023:01PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...TSXV:EPIEssa Pharma Inc
25/11/202013:00PR Newswire (Canada)ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx ConferenceTSXV:EPIEssa Pharma Inc
26/10/202022:01PR Newswire (Canada)ESSA Pharma Inc. Announces Delisting from the TSX-VTSXV:EPIEssa Pharma Inc
25/10/202001:18PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR SymposiumTSXV:EPIEssa Pharma Inc
19/10/202013:00PR Newswire (Canada)ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific SymposiaTSXV:EPIEssa Pharma Inc
21/09/202013:00PR Newswire (Canada)ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech SummitTSXV:EPIEssa Pharma Inc
17/09/202023:05PR Newswire (Canada)ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020TSXV:EPIEssa Pharma Inc
14/09/202013:00PR Newswire (Canada)ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...TSXV:EPIEssa Pharma Inc
10/09/202013:00PR Newswire (Canada)ESSA Pharma to Participate in Multiple Upcoming Investor ConferencesTSXV:EPIEssa Pharma Inc
07/08/202002:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020TSXV:EPIEssa Pharma Inc
31/07/202016:16PR Newswire (Canada)ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000TSXV:EPIEssa Pharma Inc
29/07/202015:07PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - EPITSXV:EPIEssa Pharma Inc
29/07/202015:05PR Newswire (Canada)IIROC Trading Resumption - EPITSXV:EPIEssa Pharma Inc
29/07/202003:18PR Newswire (Canada)ESSA Pharma Announces Pricing of Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022:03PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - EPITSXV:EPIEssa Pharma Inc
28/07/202022:01PR Newswire (Canada)ESSA Pharma Announces Proposed Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022:01PR Newswire (Canada)IIROC Trading Halt - EPITSXV:EPIEssa Pharma Inc
15/07/202013:00PR Newswire (Canada)ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...TSXV:EPIEssa Pharma Inc
22/06/202013:30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...TSXV:EPIEssa Pharma Inc
27/05/202013:00PR Newswire (Canada)ESSA Pharma to Present at Jefferies Virtual Healthcare ConferenceTSXV:EPIEssa Pharma Inc
15/05/202013:30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual MeetingTSXV:EPIEssa Pharma Inc
07/05/202023:05PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020TSXV:EPIEssa Pharma Inc
30/04/202023:45PR Newswire (Canada)ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate CancerTSXV:EPIEssa Pharma Inc
14/04/202000:08PR Newswire (Canada)ESSA Pharma Enters into At-The-Market Equity Offering Sales AgreementTSXV:EPIEssa Pharma Inc
31/03/202013:00PR Newswire (Canada)ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business UpdateTSXV:EPIEssa Pharma Inc
13/02/202023:48PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019TSXV:EPIEssa Pharma Inc
30/10/201911:00PR Newswire (Canada)ESSA Pharma Grants Stock OptionsTSXV:EPIEssa Pharma Inc
28/10/201912:30PR Newswire (Canada)ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu...TSXV:EPIEssa Pharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:EPI

La tua Cronologia

LSE
16PG
Agric Dev Bk.30
BOV
ALPA4Q
ALPARGATAS PN
EU
BRWT
RICI ENHANCED WTI CRUDE ...
BIT
P20W95
NLBNPIT20W95 20240920 15
XE
FC9
FCR Immobilien
NASDAQ
BCML
BayCom
BIT
P1ZAK7
NLBNPIT1ZAK7 20240621 12
EU
BE0390111749
Brussels Capital Region ...
BIT
P1WA95
NLBNPIT1WA95 20240920 1.12
BOV
G1FI34
Gold Fields
NYSE
KRC-G.CL
BIT
P1XQY9
NLBNPIT1XQY9 20991231 15...
NASDAQ
NATXX
Nations California Tax Exempt Re
BIT
P203U3
NLBNPIT203U3 20240619 18...
DGFX
GMCUSDT
Game chain Network
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network